Viatris Inc (VTRS)
13.37
+0.12
(+0.91%)
USD |
NASDAQ |
Nov 22, 16:00
13.38
0.00 (0.00%)
After-Hours: 20:00
Viatris Stock Buybacks (Quarterly): -0.60M for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -0.60M |
June 30, 2024 | -0.70M |
March 31, 2024 | 249.40M |
December 31, 2023 | -0.60M |
September 30, 2023 | -0.80M |
June 30, 2023 | -0.80M |
March 31, 2023 | 249.10M |
December 31, 2022 | -0.80M |
September 30, 2022 | -1.80M |
June 30, 2022 | -0.70M |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
Date | Value |
---|---|
June 30, 2018 | 0.00 |
March 31, 2018 | 432.00M |
December 31, 2017 | 500.20M |
September 30, 2017 | 0.00 |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | 500.00M |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 500.00M |
December 31, 2012 | 499.95M |
September 30, 2012 | 0.00 |
June 30, 2012 | 499.95M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-1.80M
Minimum
Sep 2022
249.40M
Maximum
Mar 2024
35.12M
Average
-0.60M
Median
Dec 2023
Stock Buybacks (Quarterly) Benchmarks
Lexicon Pharmaceuticals Inc | 0.00 |
Moderna Inc | -8.00M |
Baxter International Inc | -- |
Gilead Sciences Inc | 202.00M |
Perspective Therapeutics Inc | 0.123M |